• Blau Farmacêutica’s assets rose to BRL 4.24 billion at Sept. 30, 2026, from BRL 3.64 billion at year-end 2025.
• Total liabilities increased to BRL 1.87 billion from BRL 1.38 billion over the same period.
• Cash and financial investments reached BRL 1.01 billion, exceeding gross debt of BRL 910 million.
• Net cash widened to BRL 98 million from BRL 64 million in the previous quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blau Farmaceutica SA published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.